DHNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Definitive Healthcare Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.10+0.10 (+10.00%)
Close on Oct 19, 2026
- Market cap
- $116.39M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.77 (−61.67%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Definitive Healthcare Corp. reported revenue of $232.70M for the twelve months to Jun 30, 2026. Free cash flow was $28.56M.
Revenue
$232.70M
TTM Q2 2026
Operating income
-$243.35M
TTM Q2 2026
Free cash flow
$28.56M
TTM Q2 2026
EPS, diluted
-$1.60
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $116.39M
- P/E ratio
- –
- Price to sales
- 0.50
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 24.54%
Fundamentals
- Revenue
- $232.70M
- Net income
- -$168.20M
- EPS, diluted
- -$1.60
- Free cash flow
- $28.56M
- Diluted shares
- 106M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$232.70M
Gross profit
$175.09M
Operating income
-$243.35M
Net income
-$168.20M
EPS, diluted
-$1.60
Free cash flow
$28.56M
Reported periodTrailing twelve months